ISRCTN10999269Active, not recruiting未知
Personalized Hypertension Management (PHMA) based on serial assessment and telemedicine in Anhui, China
ational Natural Science Foundation of China0 sites3,420 target enrollmentStarted: July 17, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 3,420
Study Overview
Brief Summary
2021 protocol in https://pubmed.ncbi.nlm.nih.gov/33711941/ (added 15/03/2021)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Aged =18 years
- •2. Living in the selected villages for =6 months/year
- •3. Diagnosed with hypertension
Exclusion Criteria
- •Previous diagnosis of mental illness, serious illness, or disability
Investigators
Similar Trials
Completed
Phase 4
Personalised Electronic Record Supported Optimisation When Alone for Patients With HypertensionHypertensionNCT04559074Queen Mary University of London343
Completed
Not Applicable
A novel approach to treatment of hypertension in diabetic patients - A multicenter, double-blind, randomised study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design.Essential Hypertension grade I and IICirculatory SystemHypertensionISRCTN55725285Solvay Pharmaceuticals (Germany)
Recruiting
Not Applicable
Personalized hemodynamically guided antihypertensive treatment in pregnant women with mild to moderate hypertension: a randomized controlled trialgestational hypertensionpregnancy-induced-hypertension1001027310057166NL-OMON53093Medisch Universitair Ziekenhuis Maastricht368
Completed
Not Applicable
FimasaRtan-basEd BP Targets After Drug SwitcHingEssential HypertensionNCT03649646Boryung Pharmaceutical Co., Ltd4,542
Active, not recruiting
Phase 4
Optimising treatment for mild systolic hypertension in the elderly - long-term follow-upSpecialty: Primary Care, Primary sub-specialty: AgeingUKCRC code/ Disease: Cardiovascular/ Hypertensive diseasesCirculatory SystemHypertensionISRCTN97503221niversity of Oxford569